We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sensor Measures Affect of Physical Activity on Diabetes

By LabMedica International staff writers
Posted on 11 Feb 2009
An under-the-skin glucose sensor measures the affect of physical activity on diabetes. More...
The sensor consists of a tiny electrode connected to a transmitter, which is attached to the skin with an adhesive patch.

The sensor can take nearly 300 readings per day and is to be used to monitor people with diabetes' glucose levels in a new study. Diabetes experts based at Southampton General Hospital (UK) will fit the tiny devices to participants' stomachs and use them in conjunction with watch-like armbands, which will check participants' physical activity. The study, the first of its kind in the United Kingdom, will determine how much of an impact exercise has on blood glucose levels while also taking diet and insulin intake into account.

Led by Prof. Christopher Byrne and Dr. Andrew Chipperfield, the study should shed new light on the management of type 1 diabetes. Thirty volunteers aged between 18 and 75 will be supplied with the sensor and armband. Weighing less than a 7 g, the waterproof electrode and transmitter will be replaced every three days. The physical activity armband will be worn for two blocks of 2 weeks during the 12-month study to record continuous data, which can then be downloaded electronically.

Dr. Victoria King, research manager at Diabetes UK said, "Physical activity is an essential part of managing type 1 diabetes and protecting against the serious complications of the condition such as heart disease, stroke, kidney failure, blindness, and amputation. We hope that this study will equip people with type 1 diabetes with the information they need to make pragmatic decisions about physical activity and how it is likely to affect their blood glucose control. This in turn will help to protect both their short- and long-term health.”

Related Links:

Southampton General Hospital



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.